SEC Tracker
Get the app

Revolution Medicines RVMD

M. Kelsey Stephen (Officer) plans to sell 150,000 RVMD shares, about $6.1M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Sep 11, 2025
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Exercise of Stock Options
  4. 10b5-1 plan adopted: Feb 28, 2025

All of M. Kelsey Stephen's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 44,059 shares at $43.58 on Sep 11, 2025 · Form 4
  • Sold 55,941 shares at $44.48 on Sep 11, 2025 · Form 4
  • Sold 23,682 shares at $45.92 on Sep 15, 2025 · Form 4
  • Sold 1,318 shares at $46.93 on Sep 15, 2025 · Form 4
  • Sold 5,367 shares at $45.82 on Sep 16, 2025 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Revolution Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  4. Repligen RGEN public float $6.0B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025